| Mr Phillip Livingston Parker, | |
|
1301 Belleville Ave, Brewton, AL 36426-1306 | |
| (251) 809-8347 | |
| Not Available |
| Full Name | Mr Phillip Livingston Parker |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1301 Belleville Ave, Brewton, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952589004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 7063 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Phillip Livingston Parker, 1301 Belleville Ave, Brewton, AL 36426-1306 Ph: (251) 809-8347 | Mr Phillip Livingston Parker, 1301 Belleville Ave, Brewton, AL 36426-1306 Ph: (251) 809-8347 |
News Archive
A randomized controlled trial finds that 12 weeks of physical plus mental activity in inactive older adults with cognitive complaints was associated with significant improvement in cognitive function but there was no difference between intervention and control groups, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
A personal cancer treatment vaccine that targets distinctive "neoantigens" on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
Echo Therapeutics, Inc., a medical device company focused on skin permeation, continuous glucose monitoring, and associated technologies, announced today that it has re-established its operational and strategic partnership with Medical Technologies Innovation Asia, Ltd., Hong Kong, and has initiated the technology transfer process.
Marketing is not working well enough to serve the needs of the industry or the changing expectations of the patient. It is time to analyse what we are doing well, and where we need to invest effort and embrace genuine customer engagement. It's time to embrace innovative technologies, improve standard practice and roll out more valuable technologies when justified and create truly integrated, inspiring multichannel engagement campaigns.
› Verified 6 days ago
Mr. Charles Daniel Cottrell, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1121 Belleville Ave, Brewton, AL 36426 Phone: 251-867-5454 Fax: 251-867-6117 | |
Dr. Stacy Miles, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 Douglas Ave, Brewton, AL 36426 Phone: 251-867-6838 Fax: 251-867-7565 | |
Alex Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 421 Morris Ln, Brewton, AL 36426 Phone: 251-727-1265 | |
Nicole Marie Eagle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 Douglas Ave, Brewton, AL 36426 Phone: 251-867-6838 | |
Mark William Jackson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2578 Douglas Ave, Brewton, AL 36426 Phone: 251-867-5358 | |
Dr. Michael Johns, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2040 Douglas Ave, Brewton, AL 36426 Phone: 251-867-6838 Fax: 251-867-7565 |